Chronic kidney disease therapy (Maze Therapeutics)

N/A

Report date: 2024/10/10 14:08:07
NME

Base Information

Drug NameChronic kidney disease therapy (Maze Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMaze Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMaze Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A